Delivery Order V797D50358-VA25716J1568
Award Date 5/10/16
Potential Completion Date 6/10/16
Potential Value $6.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Antonio, TX 78229, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc. a $9,763 firm fixed price delivery order for 1,000 vial units of KCENTRA under an unidentified contracting vehicle. The place of performance is Park Ridge, Illinois and all items are to be delivered by March 23, 2022. KCENTRA is a plasma-derived four-factor prothrombin complex concentrate used to treat patients with acquired deficiencies of prothrombin complex coagulation factors due to warfarin or similar vitamin K antagonist...
- The Defense Logistics Agency awarded a $30,400 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 500 vials of Kcentra under contract number 4561653701. The order is being fulfilled from DMS's facility in Park Ridge, Illinois for delivery to an unknown customer by August 14, 2023. Kcentra is an intravenous blood product used to treat patients with severe bleeding or those requiring an urgent procedure. The Defense Logistics Agency manages the Department of Defense's...
- The Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, awarded a firm fixed price delivery order valued at $18,720.90 to DMS Pharmaceutical Group Inc. The order is for 1,000 vial units of KCENTRA to be delivered to a location in Park Ridge, Illinois, with performance required between September 29, 2023 and October 23, 2023. KCENTRA is a plasma-derived four-factor prothrombin complex concentrate indicated for the urgent reversal of acquired coagulation factor...
- This federal contract award is for the delivery of Kcentra 500 unit vials to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, on a firm-fixed price basis. The contract has a ceiling value of $4,478.70 and an ultimate completion date of July 11, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00,...
- The Defense Logistics Agency (DLA), a combat support agency within the Department of Defense, awarded a $29,959.20 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 1,000 vials of Kcentra. The product will be delivered from DMS's facility in Park Ridge, Illinois to an unknown DLA location by August 18, 2023. Kcentra is a blood coagulation factor replacement therapy used to treat patients with acquired coagulation factor deficiencies. This delivery order was issued against an...
- The Defense Logistics Agency Troop Support Medical awarded a $22,812 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 4562179656 KCENTRA 500 unit vials. DLA Troop Support Medical supports the Department of Defense by procuring pharmaceuticals and medical supplies. This delivery order falls under an indefinite-delivery/indefinite-quantity contract vehicle and provides 500 vials of Kcentra, a four-factor prothrombin complex concentrate used to treat patients with acquired...
- The Defense Logistics Agency awarded a delivery order valued at $9,857.28 to DMS Pharmaceutical Group Inc. for 1,000 unit vials of Kcentra on September 29, 2025, with an ultimate completion date of October 21, 2025. This firm fixed-price delivery order was issued without a set-aside designation to the woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. Kcentra is a prothrombin complex concentrate used for urgent reversal of warfarin anticoagulation in patients...
- This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) for the supply of Kcentra 1,000 unit vials. The order, valued at $17,312.80, is issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA for the provision of a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $32,842.92 firm fixed-price delivery order contract is for the supply of 4,558,788,994 units of the drug Kcentra, a blood clotting factor used to treat bleeding disorders. The contract has no set-aside designation and is part of a larger $499,999,999 indefinite delivery contract (IDC)...
- The Defense Logistics Agency awarded a delivery order under an unspecified contract vehicle to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The order is for 500 vials of KCENTRA, a blood coagulation factor, with a potential value of $8,071.20. Performance will take place in Park Ridge and be completed by June 23, 2023. The award was made on June 1, 2023 with no set-aside designation specified. As the DLA supports military treatment facilities, this order will likely provide needed...